BackChina Biologic Products Holdings Overview

China Biologic Products Holdings Long Term Debt

Latest long-term debt for CBPO: $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer average / median

Loading

China Biologic Products Holdings Long Term Debt History

Loading

China Biologic Products Holdings vs. peers: Long Term Debt Comparison

Loading

China Biologic Products Holdings Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

China Biologic Products Holdings (CBPO) FAQ

As of the most recent data (December 2020), CBPO shows a long-term debt of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CBPO's long-term debt is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether China Biologic Products Holdings is outperforming or lagging.

Tracking CBPO's long-term debt over time shows whether China Biologic Products Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has China Biologic Products Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $0) with ownership activity and broader fundamentals.

China Biologic Products Holdings's long-term debt is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.